A study on anti-tubercular drug-induced adverse reactions in South Indian district tuberculosis center
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20151370Keywords:
Tuberculosis, Directly observed treatment short course, Adverse drug reaction, Adverse drug event, Revised National Tuberculosis Control ProgrammeAbstract
Background: An adverse drug reaction (ADR) is any response to a drug which is noxious and unintended occurs at doses normally used in man for prophylaxis, diagnosis or therapy of disease or the modification of physiological function, anti-tubercular drugs can cause ADR and involving almost all systems in the body including the gastrointestinal (GI) tract, liver, skin, nervous system, and eyes.
Methods: A prospective observational study was conducted on tuberculosis (TB) patient. The suspected drug identified for ADRs and the type, nature, severity of reaction were recorded. A total of 239 patients were enrolled in the study. The patient was monitored the suspected ADRs were recorded and assessed for causality and severity.
Results: Out of 239 patients, 60 (25.11%) developed one and more than one ADR. A maximum number of tubercular patients were in age group of 21-40 years (44.4%). The majority of patients were males (69%). Incidence of ADRs based on affected organ was GI system disorders (30.33%), skin and appendages disorders (23.62%), central and peripheral nervous system disorders (15.28%), musculo-skeletal system disorders and liver and biliary disorder (9.72% each), hearing disorder (5.55%), and visual disorder accounts of (2.78%).
Conclusion: TB still becomes worldwide health problem not only on developing country but also in the developed country even the number of TB patients most large in
the developing country. The importance of developing strategies to ameliorate ADRs both to improve the quality of patient care and to control TB safely.
References
World Health Organization. Global Tuberculosis Report 2012 World Health Organization. Geneva: World Health Organization; 2012.
Maher D, Raviglione M. Global epidemiology of tuberculosis. Clin Chest Med. 2005;26(2):167-82, v.
Tripathi KD. Antitubercular drugs. Essentials of Medical Pharmcology. New Delhi: Jaypee Brothers; 2003: 705-8.
Devi S, Ramchandran R, Santha S. Adverse reaction to anti tubercular drug and their management. Bulletin. 1997;4(3,4):
Xia YY, Hu DY, Liu FY, Wang XM, Yuan YL, Tu de H, et al. Design of the anti-tuberculosis drugs induced adverse reactions in China National tuberculosis prevention and control scheme study (ADACS). BMC Public Health. 2010;10:267.
Gholami K, Kamali E, Hajiabdolbaghi M, Shalviri G. Evaluation of anti-tuberculosis induced adverse reactions in hospitalized patients. Pharm Pract (Granada). 2006;4(3):134-8.
Al-Mgoter BS. Anti-tuberculous induced hepatotoxicity. Mainichi Med J. 2010;9:52-6.
Pitayakittiwong C, Phumart P, Somsaad P, Montrisri N, Burasit W, Thongdannue V. Intensive adverse drug reactions monitoring of antituberculous drugs in tuberculosis clinic at Maha Sarakham Hospital, The 4th Annual Northeast Pharmacy Research Conference of 2012, MSU: 11-2.
Mishra S, Jena M, Jena B, Mishra SS. A study of anti-tubercular drug induced adverse reactions in patients attending pulmonary medicine Department of a Tertiary Care Teaching Hospital. Int J Pharm Sci Rev Res. 2013;21(2):308-11.
Lönnroth K, Williams BG, Stadlin S, Jaramillo E, Dye C. Alcohol use as a risk factor for tuberculosis - A systematic review. BMC Public Health. 2008;8:289.
Edoh D, Adjei R. Rapid assessment of a National tuberculosis (TB) control Programme in Eastern Ghana. Afr J Health Sci. 2002;9(3-4):159-64.
Sinha K, Marak IR, Singh WA. Adverse drug reactions in tuberculosis patients due to directly observed treatment strategy therapy: Experience at an outpatient clinic of a teaching hospital in the city of Imphal, Manipur, India. J Assoc Chest Physicians. 2013;1:50-3.
Horne N. Tuberculosis and other mycobacterial disease. In: Cook G, editor. Manson’s Tropical Diseases. Volume. 971. London: W.B. Saunders; 1996: 1015.
Dalal NP, Karandikar YS, Pandit VA. Safety evaluation of directly observed treatment short course (DOTS) regimen in a tertiary care hospital, Pune. Int J Basic Clin Pharmacol. 2014;3:369-76.
